BIOMX INC (PHGE)
US09090D1037 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 23.54M | 14.91M | 31.33M | 62.10M | 36.48M | |||
| Marketable Securities | N/A | 0.00 | 2.00M | 0.00 | 19.85M | |||
| Receivables | 950.00K | 574.00K | N/A | 0.00 | 0.00 | |||
| Other Current Assets | 3.83M | 2.15M | 3.55M | 4.54M | 4.34M | |||
| Total Current Assets | 28.32M | 17.63M | 36.88M | 66.64M | 60.67M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.28M | 7.40M | 8.65M | 9.83M | 6.66M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Intangibles | 15.29M | N/A | 0.00 | 1.52M | 3.04M | |||
| Other Non-Current Assets | 96.00K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 31.66M | 7.40M | 8.65M | 11.35M | 9.69M | |||
| TOTAL ASSETS | 59.98M | 25.03M | 45.53M | 77.99M | 70.36M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 5.79M | 4.28M | N/A | N/A | |||
| Accrued Expenses | 4.52M | 1.96M | 1.57M | 3.09M | 1.99M | |||
| Accounts Payable | 2.78M | 1.38M | 820.00K | 2.80M | 2.32M | |||
| Other Current Liabilities | 1.65M | 2.06M | 1.26M | 5.16M | 2.85M | |||
| Total Current Liabilities | 8.94M | 11.18M | 7.94M | 11.04M | 7.16M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 5.40M | 10.59M | 14.41M | 0.00 | |||
| Other Non-Current Liabilities | 13.14M | 5.37M | 5.96M | 5.00M | 5.73M | |||
| Total Non-Current Liabilities | 13.14M | 10.77M | 16.55M | 19.42M | 5.73M | |||
| TOTAL LIABILITIES | 22.08M | 21.95M | 24.49M | 30.46M | 12.89M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -166.18M | -162.97M | -136.80M | -108.48M | -72.26M | |||
| Additional Paid In Capital | 185.43M | 166.05M | 157.84M | 156.02M | 129.73M | |||
| Common Shares | 18.65M | 3.00K | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 18.18M | 45.98M | 29.98M | 29.75M | 23.26M | |||
| Tangible Book Value per Share | 0.22 | 0.07 | 0.70 | 1.55 | 2.34 | |||
| Total Shareholders' Equity | 37.90M | 3.08M | 21.04M | 47.54M | 57.47M | |||
| TOTAL LIABILITIES AND EQUITY | 59.98M | 25.03M | 45.53M | 77.99M | 70.36M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 1.75 | 0.50 | 0.30 | N/A | |||
| Current Ratio | 3.17 | 1.58 | 4.64 | 6.04 | 8.47 | |||
| Return On Assets (ROA) | -14.51% | -104.55% | -62.20% | -46.45% | -42.77% | |||
| Return On Equity (ROE) | -22.97% | -849.37% | -134.60% | -76.21% | -52.36% | |||
All data in USD , ROIC based on taxRate of 0.21